fda warning letters glp-1 compounding october 2025

fda warning letters glp-1 compounding october 2025 Congress Introduces SAFE Drugs Act of 2025, Expanding Oversight of Compounded Drugs and Telehealth Providers FDA telehealth crackdown highlights role

Name: fda warning letters glp-1 compounding october 2025 Congress Introduces SAFE Drugs Act of 2025, Expanding Oversight of Compounded Drugs and Telehealth Providers FDA telehealth crackdown highlights role
Brand: councilforsecureamerica.org
SKU: 53508313745
Price: 25.86 USD
Availability: InStock
Rating: 4.1665 (5 reviews)

SKU: 53508313745

4.2

EUR25.86 EUR75.86

Pay in 4 interest-free payments of $6.46 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Description

PSM Executive Director Shabbir Imber Safdar released the following statement in response to news that Hims & Hers is now compounding pill versions of a newly approved GLP-1 weight-loss drug

It can inhibit a key step of the folate cycle (at the level of 5-methyltetrahydrofolate), leading to the accumulation of AICAR a natural analog of AMP that potently activates AMPK